GlassScriptPhysician profile
Granger B Wong
NPI 1225013790
$8,487.10
in general payments reported to CMS, 2019-2025
31 companies · $1,977 in 2025
The $1,977 reported for 2025 was more than what 84% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,163 · 2020: $1,000 · 2021: $1,304 · 2022: $1,571 · 2023: $632 · 2024: $841 · 2025: $1,977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,449.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,117.15 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Axogen | $835.28 | 2019-2025 | |
| Sientra, INC. | $732.39 | 2019-2022 | |
| Mentor Worldwide LLC | $656.27 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Dilon Technologies, INC. | $539.62 | 2025 | Hemoblast Bellows |
| Kls-Martin L.P. | $457.37 | 2019-2023 | |
| Allergan, INC. | $386.36 | 2019-2022 | |
| Galderma Laboratories, L.P. | $385.82 | 2019-2024 | Dysport |
| Abbvie INC. | $345.80 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Innovation Technologies INC | $329.26 | 2024-2025 | Irrisept |
| Tela Bio, INC. | $319.06 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Polynovo North America LLC | $240.72 | 2025 | Novosorb Btm |
| Musculoskeletal Transplant Foundation INC. | $239.28 | 2021-2023 | |
| Acell, INC. | $230.40 | 2019-2020 | |
| Motiva USA, LLC | $171.22 | 2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $156.19 | 2022 | |
| Next Science LLC | $143.26 | 2024 | Xperience, Surgx, Blastx |
| Stryker Corporation | $129.23 | 2023 | Variax |
| Polarityte, INC. | $127.68 | 2020 | |
| Lifenet Health | $126.50 | 2024 | Theragenesis Wound Matrix |
| Baudax Bio INC. | $125.06 | 2021 | |
| Zimmer Biomet Holdings, INC. | $119.30 | 2020 | |
| Checkpoint Surgical, INC | $102.68 | 2019 | |
| Tei Biosciences INC | $93.80 | 2019 | |
| Medtronic, INC. | $86.82 | 2021-2022 | |
| Derma Sciences, INC. | $83.73 | 2019 | |
| Medtronic USA, INC. | $59.65 | 2019-2020 | |
| Intra-Sana Laboratories | $51.21 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Baxter Healthcare | $43.84 | 2021 | |
| Tepha INC | $35.31 | 2019 | |
| Kerecis Limited | $16.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Granger Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.